Clinical Trial Update: Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update on XC8 10 mg film-coated tablets for dry non-productive cough associated with acute respiratory viral infection; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Influenza Human
• Respiratory Infection

Drugs mentioned

• XC8

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Common Cold, Acute Respiratory Infection | Phase 2 | Status: COMPLETED